Accepted at 5:40 a.m. Jul, 13, 2026 by Ahmed7
Author: jkogut
Related Note: 1488765280375 2
Rationale for change

added memory trick from NID:1473995740705

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::06_Intracerebral_Hemorrhage_(ICH):_Etiology,_Pathophysiology,_Clinical_Features,_Diagnostics,_Treatment #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#AMBOSS::wx0hAR #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::02_Warfarin_(MOA,_Indications,_AR,_CI) #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step2_v12::#UWorld::Step::4736 #AK_Step1_v12::#AMBOSS::tQaXB4 #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::17_Hypercoagulable_States #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States::Extra #AK_Step1_v12::#NBME::32 #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#FirstAid::07_Hematology::01_Coagulation_Disorders::01_Normal_Hemostasis #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::#UWorld::COMLEX::101516 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#NinjaNerd::12_Neurology::03_Pathology::05_Acute_Ischemic_Stroke:_Etiology,_Pathophysiology,_Clinical_Features,_Diagnostics,_Treatment